{"entity":{"type":"insider","cik":"0001721544","url":"/insider/0001721544","json_url":"/insider/0001721544.json","name":"McClellan Michael James","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":6,"n_filings":6,"first":"2018-03-20","last":"2019-11-06","span_basis":"filed_date"},"name_variants":[{"name":"McClellan Michael James","source":"filing","n_filings":6,"first_seen":"2018-03-20","last_seen":"2019-11-06"}],"transactions":[{"id":8520152,"accession":"0001209191-19-055414","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-055414","line_url":"/filing/0001209191-19-055414#line-2","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001721544","owner_name":"McClellan Michael James","owner_display_name":"McClellan Michael James","owner_url":"/insider/0001721544","role":"Officer (EVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Financial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":242.0,"shares_display":"242","price_per_share":8.8341,"price_display":"8.83","price_state":"stated","total_value":2137.8522,"total_display":"2,137.85","total_whole":"2,138","shares_owned_after":15898.272,"shares_owned_after_display":"15,898.27","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-05","filed_date":"2019-11-06","scope":"insider"},{"id":8728436,"accession":"0001209191-19-050264","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-050264","line_url":"/filing/0001209191-19-050264#line-2","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001721544","owner_name":"McClellan Michael James","owner_display_name":"McClellan Michael James","owner_url":"/insider/0001721544","role":"Officer (EVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Financial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1406.0,"shares_display":"1,406","price_per_share":7.8313,"price_display":"7.83","price_state":"stated","total_value":11010.8078,"total_display":"11,010.81","total_whole":"11,011","shares_owned_after":15445.272,"shares_owned_after_display":"15,445.27","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-09-18","filed_date":"2019-09-20","scope":"insider"},{"id":7946221,"accession":"0001209191-19-020159","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-020159","line_url":"/filing/0001209191-19-020159#line-2","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001721544","owner_name":"McClellan Michael James","owner_display_name":"McClellan Michael James","owner_url":"/insider/0001721544","role":"Officer (EVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Financial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":230.0,"shares_display":"230","price_per_share":16.6251,"price_display":"16.63","price_state":"stated","total_value":3823.773,"total_display":"3,823.77","total_whole":"3,824","shares_owned_after":12760.272,"shares_owned_after_display":"12,760.27","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-18","filed_date":"2019-03-19","scope":"insider"},{"id":7875720,"accession":"0001209191-19-016089","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-016089","line_url":"/filing/0001209191-19-016089#line-2","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001721544","owner_name":"McClellan Michael James","owner_display_name":"McClellan Michael James","owner_url":"/insider/0001721544","role":"Officer (EVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Financial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":363.0,"shares_display":"363","price_per_share":16.8833,"price_display":"16.88","price_state":"stated","total_value":6128.6379,"total_display":"6,128.64","total_whole":"6,129","shares_owned_after":12330.272,"shares_owned_after_display":"12,330.27","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-04","filed_date":"2019-03-05","scope":"insider"},{"id":6913824,"accession":"0001209191-18-057493","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-057493","line_url":"/filing/0001209191-18-057493#line-2","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001721544","owner_name":"McClellan Michael James","owner_display_name":"McClellan Michael James","owner_url":"/insider/0001721544","role":"Officer (EVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Financial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":346.0,"shares_display":"346","price_per_share":22.7316,"price_display":"22.73","price_state":"stated","total_value":7865.1336,"total_display":"7,865.13","total_whole":"7,865","shares_owned_after":11644.272,"shares_owned_after_display":"11,644.27","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-11-05","filed_date":"2018-11-07","scope":"insider"},{"id":6099938,"accession":"0001209191-18-020861","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-020861","line_url":"/filing/0001209191-18-020861#line-2","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001721544","owner_name":"McClellan Michael James","owner_display_name":"McClellan Michael James","owner_url":"/insider/0001721544","role":"Officer (EVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Financial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":287.0,"shares_display":"287","price_per_share":17.878,"price_display":"17.88","price_state":"stated","total_value":5130.986,"total_display":"5,130.99","total_whole":"5,131","shares_owned_after":11295.272,"shares_owned_after_display":"11,295.27","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-03-19","filed_date":"2018-03-20","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":6,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":6,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":6},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000818686","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","url":"/issuer/0000818686","role":"Officer (EVP, Chief Financial Officer)","n_filings":6,"first_seen":"2018-03-20","last_seen":"2019-11-06"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001721544","retrieved_at":"2026-08-26T09:49:52+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}